(1)
Mạnh, P. D.; Toàn, P. K.; Huy, T. L. 82. Gefitinib Rechallenge After Osimertinib-Induced Interstitial Lung Disease: A Case Report and Literature Review. TCNCYH 2025, 195, 795-800.